Publications by authors named "Jan Musialkiewicz"

Claim this Profile
T
The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.
Maciej Kołodziej, Violetta Rosiek, Jan Musiałkiewicz, Aleksandra Ledwon, Anna Lewczuk-Myślicka

Nucl Med Rev Cent East Eur· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple endocrinopathies presenting simultaneously with insulinoma as the leading manifestation.
Jan Musiałkiewicz, Paweł Komarnicki, Joanna Kapturzak, Adam Maciejewski, Sebastian Sowier

Am J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours.
Jan Musiałkiewicz, Marek Ruchała, Paweł Komarnicki, Adam Maciejewski, Joanna Sienkiewicz

Endocr Connect· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives.
Paweł Komarnicki, Adam Maciejewski, Jan Musiałkiewicz, Michalina Czupińska, George Mastorakos

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors.
Kosma Woliński, Paweł Komarnicki, Adam Maciejewski, Jan Musiałkiewicz, Paweł Gut

Endocr Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthyroidism caused by massive toxic nodular goiter accompanied by primary hyperparathyroidism.
Jan Musiałkiewicz, Paweł Komarnicki, Paulina Ziółkowska, Rafał Czepczyński, Marek Ruchała

Pol Arch Intern Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid-onset Cushing syndrome induced by adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor: a therapeutic challenge.
Paweł Komarnicki, Jan Musiałkiewicz, Adam Maciejewski, Paweł Gut, Marek Ruchała

Pol Arch Intern Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum β-hCG as a Biomarker in Pancreatic Neuroendocrine Tumors: Rethinking Single-Analyte Approach.
Paweł Komarnicki, Paweł Gut, Maja Cieślewicz, Jan Musiałkiewicz, Adam Maciejewski

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure.
Paweł Komarnicki, Paweł Gut, Jan Musiałkiewicz, Maja Cieślewicz, Adam Maciejewski

Endocr Connect· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, Adam Maciejewski, Paweł Gut

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary carcinoids - analysis of early and long-term surgical treatment outcomes in a group of 90 patients.
Mariusz Kasprzyk, Jan Musiałkiewicz, Mikołaj Kolasiński, Kajetan Jagiełka, Wojciech Dyszkiewicz

Kardiochir Torakochirurgia Pol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis